Back to Atlas
CTransientStandard research/education caution
CMP-0391
Investigational/discontinued
MK-0773
Ergogenic / SARM
Lean mass and physical-function research positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- SARM
- Primary mechanism
- Selective androgen receptor agonism
- Primary market use
- Sarcopenia/frailty research
Pharmacology
- Molecular weight (Da)
- 445.5
- Oral bioavailability
- Oral
- Half-life
- ~5-6 h
- Route tags
- Route-dependent / verify
- Evidence level
- Human/Clinical
- Clinical status
- Investigational/discontinued
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Clinical data but not approved; modest efficacy and safety uncertainties